CLAG-based induction therapy in previously untreated high risk acute myeloid leukemia patients
详细信息 查看全文
- 作者：Karen Seiter ; karen_seiter@nymc.edu" class="auth_mail" title="E-mail the corresponding author ; Nasir Ahmed ; Azfar Shaikh ; Paul Baskind ; Delong Liu
- 关键词：Acute myeloid leukemia ; CLAG ; Secondary AML ; Previously untreated
- 刊名：Leukemia Research
- 出版年：2016
- 出版时间：July 2016
- 年：2016
- 卷：46
- 期：Complete
- 页码：74-78
- 全文大小：599 K
文摘
- •
20 Previously untreated AML patients were treated with CLAG based induction therapy.
- •
The CR rate was 65% after one cycle and 80% after two cycles of therapy.
- •
The mean duration of response is 36.8 months and the median overall survival is 29.0 months.
- •
Patients with de novo AML had a 90.9% response to induction therapy and a median overall survival of 38.5 months.